Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Site-specific conjugation of linker drugs to antibodies and resulting ADCs

Site-specific conjugation of linker drugs to antibodies and resulting ADCs

US Patent 10407743 · Granted Sep 10, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual conjugation process for preparing antibody-drug conjugates2025
Site-specific conjugation of linker drugs to antibodies and resulting ADCs2024
Site-specific conjugation of linker drugs to antibodies and resulting ADCs2024
Dual conjugation process for preparing antibody-drug conjugates2023
Anti-5T4 antibodies and antibody-drug conjugates2023
Anti-5T4 antibodies and antibody-drug conjugates2023
Non-linear self-immolative linkers and conjugates thereof2022
Site-specific conjugation of linker drugs to antibodies and resulting ADCS2021
Site-specific conjugation of linker drugs to antibodies and resulting ADCS2021
Site-specific conjugation of linker drugs to antibodies and resulting ADCS2021
Site-specific conjugation of linker drugs to antibodies and resulting ADCS2021
Conjugates of CC-1065 analogs and bifunctional linkers2021